Stepan Reports First Quarter 2026 Results
Rhea-AI Summary
Stepan (NYSE:SCL) reported Q1 2026 results with net loss of $41.4 million and adjusted net income of $10.3 million. Consolidated adjusted EBITDA was $49.6 million, down 14% year-over-year. Results included a $65.4 million pre-tax restructuring charge and announced land sale agreement for $30 million.
Organic net sales rose 4% while organic volume was flat; free cash flow was negative $14.0 million.
Positive
- Adjusted EBITDA of $49.6 million
- Organic net sales up 4% year-over-year
- Agreement to sell land near Millsdale for $30 million
Negative
- GAAP net loss of $41.4 million
- $65.4 million pre-tax restructuring charge
- Free cash flow negative $14.0 million for the quarter
Key Figures
Market Reality Check
Peers on Argus
Pre‑earnings, SCL was up 1.15% with mixed peer moves: some specialty/chemicals peers like ECVT and KOP were up, while ODC and MATV were down. With no clear target direction from the momentum scanner and only one peer flagged, the setup looked more stock‑specific than a broad sector rotation.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 23 | Q4 & FY 2025 results | Positive | -20.4% | Q4 and full-year 2025 earnings with EBITDA growth and Project Catalyst launch. |
| Oct 29 | Q3 2025 results | Neutral | -0.4% | Mixed Q3 2025 earnings with higher adjusted EBITDA but lower net income. |
| Jul 30 | Q2 2025 results | Positive | -9.7% | Strong Q2 2025 results with higher net income and adjusted EBITDA growth. |
| Apr 29 | Q1 2025 results | Positive | +7.1% | Q1 2025 beat with 42% net income growth and 12% adjusted EBITDA increase. |
| Feb 19 | Q4 2024 results | Neutral | +0.1% | Q4 2024 swing back to profit but weaker adjusted net income due to one-offs. |
Recent earnings releases often showed fundamentally positive or mixed results but were followed by modestly negative average price reactions, suggesting a tendency for the stock to underperform around earnings.
Over the last year, Stepan’s earnings reports have highlighted steady net sales growth and generally rising adjusted EBITDA, alongside start‑up and restructuring costs. Q2 and Q3 2025 showed higher adjusted EBITDA but mixed net income trends, while Q4 2025 and full‑year 2025 delivered EBITDA growth and introduced Project Catalyst. Today’s Q1 2026 report updates that story by booking sizable restructuring charges tied to Project Catalyst and lower adjusted earnings, against modest top‑line growth and ongoing portfolio/footprint optimization.
Historical Comparison
In the past year, Stepan’s earnings releases produced an average move of -4.66%, with several cases where solid fundamental updates were followed by negative share reactions.
Earnings releases show a progression from 2024–2025 EBITDA growth and new Pasadena capacity to 2026 restructuring under Project Catalyst, with Q1 2026 reflecting sizable charges and softer adjusted earnings versus prior periods.
Market Pulse Summary
This announcement details Q1 2026 results marked by a reported -$41.4M net loss driven by a $65.4M restructuring charge, alongside a 2% net sales increase and $49.6M adjusted EBITDA, down 14% year-over-year. It updates progress on Project Catalyst, including facility closures and an expected $30M land sale. Investors may track future quarters for adjusted EBITDA trends, cash generation, and how quickly restructuring actions translate into sustainable margin and earnings improvement.
Key Terms
ebitda financial
adjusted ebitda financial
free cash flow financial
stock appreciation rights financial
restricted stock units financial
schedule 13g/a regulatory
def 14a regulatory
AI-generated analysis. Not financial advice.
First Quarter 2026 Highlights
- Reported net income was a
$41.4 million $19.7 million $65.4 million $10.3 million 47% versus the prior year, largely due to lower Surfactant earnings and higher interest expense. The higher interest expense reflects lower capitalized interest income due to the start-up of thePasadena, TX site. - EBITDA(2) was a negative
$16.5 million $58.0 million $65.4 million $49.6 million 14% year-over-year. - Organic sales volume was flat year-over-year as strong demand within Crop Productivity, Oilfield and Industrial Cleaning was offset by soft European Polymers demand.
- Cash from Operations was
$16.9 million $14.0 million - Pre-tax earnings include a
$65.4 million Fieldsboro, NJ site and select assets at its Elwood (Millsdale), IL and Stalybridge,UK facilities. The cash impact associated with this restructuring charge was less than$1.0 million - The Company has entered into an agreement to sell a parcel of land near its Millsdale site for
$30 million
"We are executing Project Catalyst safely and in line with expectations despite early quarter weather-related impacts and the new geopolitical challenges. Global adjusted EBITDA was down
Financial Summary
Three Months Ended | ||||||||||||
($ in thousands, except per share data) | 2026 | 2025 | % | |||||||||
Net Sales | $ | 604,509 | $ | 593,255 | 2 | % | ||||||
Operating Income (Loss) | $ | (49,622) | $ | 28,288 | NM | |||||||
Net Income (Loss) | $ | (41,406) | $ | 19,711 | NM | |||||||
Earnings per Diluted Share | $ | (1.81) | $ | 0.86 | NM | |||||||
Adjusted Net Income * | $ | 10,313 | $ | 19,310 | (47) | % | ||||||
Adjusted Earnings per | $ | 0.45 | $ | 0.84 | (46) | % | ||||||
* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
Percentage Change in Net Sales
Net sales in the first quarter of 2026 increased
Three Months Ended | ||||
Volume | (3) | % | ||
Selling Price & Mix | 1 | % | ||
Foreign Translation | 4 | % | ||
Total | 2 | % | ||
Segment Results
Three Months Ended | ||||||||||||
($ in thousands) | 2026 | 2025 | % | |||||||||
Net Sales | ||||||||||||
Surfactants | $ | 453,687 | $ | 430,337 | 5 | % | ||||||
Polymers | $ | 130,029 | $ | 146,116 | (11) | % | ||||||
Specialty Products | $ | 20,793 | $ | 16,802 | 24 | % | ||||||
Total Net Sales | $ | 604,509 | $ | 593,255 | 2 | % | ||||||
Three Months Ended | ||||||||||||
($ in thousands, all amounts pre-tax) | 2026 | 2025 | % | |||||||||
Operating Income (Loss) | ||||||||||||
Surfactants | $ | 18,548 | $ | 28,930 | (36) | % | ||||||
Polymers | $ | 8,822 | $ | 8,018 | 10 | % | ||||||
Specialty Products | $ | 4,715 | $ | 5,508 | (14) | % | ||||||
Total Segment | $ | 32,085 | $ | 42,456 | (24) | % | ||||||
Corporate Expenses | $ | (81,707) | $ | (14,168) | 477 | % | ||||||
Consolidated | $ | (49,622) | $ | 28,288 | (275) | % | ||||||
Three Months Ended | ||||||||||||
($ in millions) | 2026 | 2025 | % | |||||||||
EBITDA | $ | (16.5) | $ | 58.0 | (128) | % | ||||||
Adjusted EBITDA | ||||||||||||
Surfactants | $ | 41.1 | $ | 48.3 | (15) | % | ||||||
Polymers | $ | 17.4 | $ | 16.1 | 8 | % | ||||||
Specialty Products | $ | 6.2 | $ | 7.0 | (11) | % | ||||||
Unallocated Corporate | $ | (15.1) | $ | (13.9) | 9 | % | ||||||
Consolidated Adjusted EBITDA | $ | 49.6 | $ | 57.5 | (14) | % | ||||||
Consolidated adjusted EBITDA(2) decreased
- Surfactant net sales were
$453.7 million 5% versus the prior year. Selling prices were up2% primarily due to pass through of higher raw material costs, improved product and customer mix, along with pricing actions. Organic sales volume was up2% , driven by strong demand within the Industrial Cleaning, Oilfield and Crop Productivity end markets. Total sales volume declined2% due tothe Philippines divestiture in the fourth quarter of 2025. The Company achieved volume growth in all global regions except Asia. Foreign currency translation positively impacted net sales by5% . Surfactant adjusted EBITDA(2) for the quarter decreased$7.2 million 15% , versus the prior year. This decrease was primarily due to higher overhead due to production timing differences inAsia , competitive pressures inMexico , the severe cold snap in theU.S. and higher oleochemicals raw material costs. - Polymer net sales were
$130.0 million 11% decrease versus the prior year. Selling prices decreased8% , primarily due to the pass-through of lower raw material costs and competitive pressures. Sales volume decreased6% in the quarter. North American sales volume was up5% but this was more than offset by a19% decline in Europe. Foreign currency translation positively impacted net sales by3% during the quarter. Polymer adjusted EBITDA(2) increased$1.3 million 8% , versus the prior year primarily due to global margin improvement. - Specialty Products net sales were
$20.8 million 24% increase versus the prior year, primarily due to higher sales volume. Specialty Products adjusted EBITDA(2) decreased$0.8 million 11% . The decrease in adjusted EBITDA(2) was primarily due to product mix and lower margins within the medium chain triglycerides product line due to higher raw material costs.
Outlook
"We are executing on Project Catalyst, which is our comprehensive plan designed to further optimize our asset base and create a more productive and agile organization to enable growth. During the first quarter we executed our plans to close our
Notes
(1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.
(2) EBITDA and adjusted EBITDA are non-GAAP measures. See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.
(3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures. Cash generated from operations was
Conference Call
Stepan Company will host a conference call to discuss its first quarter results at 8:00 a.m. ET (7:00 a.m. CT) on April 28, 2026. The call can be accessed by phone and webcast. To access the call by phone, please click on this Registration Link, complete the form and you will be provided with dial in details and a PIN. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. The webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.
Headquartered in
The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.
There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; our ability to realize cost savings or operating efficiencies associated with strategic initiatives; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including changes in global trade policies, tariffs, retaliatory measures and countermeasures, currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; potential adverse tax consequences due to the international scope of our business; downgrades in our credit ratings or our ability to access capital markets; global political, military, security or other instability and increased security regulations; costs, delays and miscalculations in capacity needs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants. In addition to the risks described in the Company's periodic reports, the restructuring actions described herein may involve risks related to the execution of facility closures and asset decommissioning, potential operational disruptions, impacts on employees and local communities, environmental compliance, and the realization of anticipated cost savings and efficiencies.
These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable laws.
* * * * *
Tables follow
Table I | ||||||||
STEPAN COMPANY | ||||||||
For the Three Months Ended March 31, 2026 and 2025 | ||||||||
(Unaudited – in 000's, except per share data) | ||||||||
Three Months Ended | ||||||||
2026 | 2025 | |||||||
Net Sales | $ | 604,509 | $ | 593,255 | ||||
Cost of Sales | 539,658 | 517,792 | ||||||
Gross Profit | 64,851 | 75,463 | ||||||
Operating Expenses: | ||||||||
Selling | 12,166 | 12,108 | ||||||
Administrative | 21,313 | 21,414 | ||||||
Research, Development and Technical Services | 14,993 | 14,649 | ||||||
Deferred Compensation Expense | 562 | (996) | ||||||
49,034 | 47,175 | |||||||
Business Restructuring | 65,439 | - | ||||||
Operating Income (Loss) | (49,622) | 28,288 | ||||||
Other Income (Expense): | ||||||||
Interest, Net | (5,011) | (4,126) | ||||||
Other, Net | 144 | 502 | ||||||
(4,867) | (3,624) | |||||||
Income (Loss) Before Provision for Income Taxes | (54,489) | 24,664 | ||||||
Provision for Income Taxes | (13,083) | 4,953 | ||||||
Net Income (Loss) | (41,406) | 19,711 | ||||||
Net Income (Loss) Per Common Share | ||||||||
Basic | $ | (1.81) | $ | 0.86 | ||||
Diluted | $ | (1.81) | $ | 0.86 | ||||
Shares Used to Compute Net Income Per | ||||||||
Basic | 22,888 | 22,867 | ||||||
Diluted | 22,888 | 22,890 | ||||||
Table II | ||||||||||||||||
Reconciliation of Non-GAAP Net Income (Loss) and Earnings per Diluted Share* | ||||||||||||||||
Three Months Ended | ||||||||||||||||
($ in thousands, except per share amounts) | 2026 | EPS | 2025 | EPS | ||||||||||||
Net Income (Loss) Reported | $ | (41,406) | $ | (1.81) | $ | 19,711 | $ | 0.86 | ||||||||
Deferred Compensation (Income) Expense | $ | 477 | $ | 0.02 | $ | (470) | $ | (0.02) | ||||||||
Environmental Remediation | $ | 78 | $ | 0.00 | $ | 69 | $ | 0.00 | ||||||||
Business Restructuring | $ | 51,164 | $ | 2.24 | $ | - | $ | - | ||||||||
Adjusted Net Income | $ | 10,313 | $ | 0.45 | $ | 19,310 | $ | 0.84 | ||||||||
* All amounts in this table are presented after-tax |
The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition. The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years. These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies. The Company's Annual Report on Form 10-K for the year ended December 31, 2025 contains additional information regarding the use of non-GAAP financial measures.
Summary of First Quarter 2026 Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.
- Deferred Compensation: The first quarter of 2026 reported net income includes
$0.5 million $0.5 million - Environmental Remediation: The first quarter of 2026 reported net income includes
$0.1 million $0.1 million - Business Restructuring: The first quarter of 2026 reported net income includes
$51.2 million
Table III | ||||||||||||||||
Reconciliation of Pre-Tax to After-Tax Adjustments | ||||||||||||||||
Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. The cumulative tax effect is typically calculated using the statutory tax rates for the jurisdictions in which the transactions occurred. | ||||||||||||||||
Three Months Ended | ||||||||||||||||
($ in thousands, except per share amounts) | 2026 | EPS | 2025 | EPS | ||||||||||||
Pre-Tax Adjustments | ||||||||||||||||
Deferred Compensation (Income) Expense | $ | 628 | $ | (626) | ||||||||||||
Environmental Remediation Expense | $ | 102 | $ | 92 | ||||||||||||
Business Restructuring | $ | 65,439 | $ | - | ||||||||||||
Total Pre-Tax Adjustments | $ | 66,169 | $ | (534) | ||||||||||||
Cumulative Tax Effect on Adjustments | $ | (14,450) | $ | 133 | ||||||||||||
After-Tax Adjustments | $ | 51,719 | $ | 2.26 | $ | (401) | $ | (0.02) | ||||||||
Table IV | ||||||||||||||||||||
Deferred Compensation Plans | ||||||||||||||||||||
The full effect of the deferred compensation plans on quarterly pre-tax income was | ||||||||||||||||||||
2026 | 2025 | |||||||||||||||||||
3/31 | 12/31 | 9/30 | 6/30 | 3/31 | ||||||||||||||||
Stepan Company | $ | 49.98 | $ | 47.36 | $ | 47.70 | $ | 54.58 | $ | 55.04 | ||||||||||
Three Months Ended | ||||||||
($ in thousands) | 2026 | 2025 | ||||||
Deferred Compensation | ||||||||
Operating Income (Expense) | $ | (562) | $ | 996 | ||||
Other, net – Mutual Fund Gain (Loss) | (66) | (370) | ||||||
Total Pre-Tax | $ | (628) | $ | 626 | ||||
Total After-Tax | $ | (477) | $ | 470 | ||||
Effects of Foreign Currency Translation
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into
($ in millions) | Three Months Ended | Change | Change | |||||||||||||
2026 | 2025 | |||||||||||||||
Net Sales | $ | 604.5 | $ | 593.3 | $ | 11.2 | $ | 25.3 | ||||||||
Gross Profit | 64.9 | 75.5 | $ | (10.6) | 2.5 | |||||||||||
Operating Income | (49.6) | 28.3 | $ | (77.9) | 1.3 | |||||||||||
Pretax Income | (54.5) | 24.7 | $ | (79.2) | 1.4 | |||||||||||
Corporate Expenses
Three Months Ended | ||||||||||||
($ in thousands) | 2026 | 2025 | % | |||||||||
Total Corporate Expenses | $ | 81,707 | $ | 14,168 | 477 | % | ||||||
Less: | ||||||||||||
Deferred Compensation (Income) Expense | $ | 562 | $ | (996) | (156) | % | ||||||
Environmental Remediation | $ | 102 | $ | 92 | 11 | % | ||||||
Business Restructuring | $ | 65,439 | $ | - | NM | |||||||
Adjusted Corporate Expenses | $ | 15,604 | $ | 15,072 | 4 | % | ||||||
Table V | ||||||||
Stepan Company | ||||||||
Consolidated Balance Sheets | ||||||||
March 31, 2026 and December 31, 2025 | ||||||||
March 31, 2026 | December 31, | |||||||
ASSETS | ||||||||
Current Assets | $ | 906,238 | $ | 858,959 | ||||
Property, Plant & Equipment, Net | 1,148,164 | 1,219,627 | ||||||
Other Assets | 278,935 | 279,116 | ||||||
Total Assets | $ | 2,333,337 | $ | 2,357,702 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities | $ | 720,453 | $ | 666,494 | ||||
Deferred Income Taxes | 11,052 | 11,450 | ||||||
Long-term Debt | 328,415 | 340,975 | ||||||
Other Non-current Liabilities | 80,393 | 94,773 | ||||||
Total Stepan Company Stockholders' Equity | 1,193,024 | 1,244,010 | ||||||
Total Liabilities and Stockholders' Equity | $ | 2,333,337 | $ | 2,357,702 | ||||
Selected Balance Sheet Information
The Company's total debt increased by
($ in millions) | March 31, | December 31, | ||||||
Net Debt | ||||||||
Total Debt | $ | 651.7 | $ | 626.7 | ||||
Cash | 140.8 | 132.7 | ||||||
Net Debt | $ | 510.9 | $ | 494.0 | ||||
Equity | 1,193.0 | 1,244.0 | ||||||
Net Debt + Equity | $ | 1,703.9 | $ | 1,738.0 | ||||
Net Debt / (Net Debt + Equity) | 30 | % | 28 | % | ||||
The major working capital components were:
($ in millions) | March 31, | December 31, | ||||||
Net Receivables | $ | 433.7 | $ | 388.0 | ||||
Inventories | 289.0 | 298.8 | ||||||
Accounts Payable | (285.7) | (261.7) | ||||||
$ | 437.0 | $ | 425.1 | |||||
Table VI | ||||||||||||||||||||
Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA | ||||||||||||||||||||
Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income. | ||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||
($ in millions) | Surfactants | Polymers | Specialty | Unallocated | Consolidated | |||||||||||||||
Operating Income (Loss) | $ | 18.5 | $ | 8.8 | $ | 4.7 | $ | (81.7) | $ | (49.6) | ||||||||||
Depreciation and Amortization | 22.6 | 8.6 | 1.5 | 0.4 | 33.0 | |||||||||||||||
Other, Net Income | - | - | - | 0.1 | 0.1 | |||||||||||||||
EBITDA | $ | (16.5) | ||||||||||||||||||
Deferred Compensation | - | - | - | 0.6 | 0.6 | |||||||||||||||
Environmental Remediation | - | - | - | 0.1 | 0.1 | |||||||||||||||
Business Restructuring | - | - | - | 65.4 | 65.4 | |||||||||||||||
Adjusted EBITDA | $ | 41.1 | $ | 17.4 | $ | 6.2 | $ | (15.1) | $ | 49.6 | ||||||||||
Three Months Ended | ||||||||||||||||||||
($ in millions) | Surfactants | Polymers | Specialty | Unallocated | Consolidated | |||||||||||||||
Operating Income | $ | 28.9 | $ | 8.0 | $ | 5.5 | $ | (14.2) | $ | 28.2 | ||||||||||
Depreciation and Amortization | 19.4 | 8.1 | 1.5 | 0.3 | 29.3 | |||||||||||||||
Other, Net Income | - | - | - | 0.5 | 0.5 | |||||||||||||||
EBITDA | $ | 58.0 | ||||||||||||||||||
Deferred Compensation | - | - | - | (0.6) | (0.6) | |||||||||||||||
Environmental Remediation | - | - | - | 0.1 | 0.1 | |||||||||||||||
Adjusted EBITDA | $ | 48.3 | $ | 16.1 | $ | 7.0 | $ | (13.9) | $ | 57.5 | ||||||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-first-quarter-2026-results-302755237.html
SOURCE Stepan Company